Please select to continue. This page is intended for UK patients who have been prescribed SPIRIVA® Respimat® (tiotropium) and members of the public. This information is not intended to replace the advice of a healthcare professional.

SPIRIVA Respimat (tiotropium) can be used in adult patients with chronic obstructive pulmonary disease (COPD) or patients aged 6 years and older with Severe Asthma.

Please select the relevant option below to find out more information.

Quick Links

Summary of Product Characteristics
Patient Information Leaflet

NP-GB-103747 | November 2024

Side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any side effects not listed in package leaflet.
You can also report side effects directly to the Yellow Card scheme
of www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of the medicine.